Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With
Type 2 Diabetes
A Randomized, Controlled Trial
John B. Buse, MD, PhD; Richard M. Bergenstal, MD; Leonard C. Glass, MD; Cory R. Heilmann, PhD; Michelle S. Lewis, PhD;
Anita Y.M. Kwan, MS; Byron J. Hoogwerf, MD; and Julio Rosenstock, MD
Ann Intern Med. 2011;154.
